The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand

Journal of Clinical Investigation

Volumn 99, Issue 11, 1997, Pages 2682-2690

  Takada, Moriatsu ^a   Nadeau, Kari C ^b   Shaw, Gray D ^c   Marquette, Kimberley A ^c   Tilney, Nicholas L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c PFIZER INC   (United States)

Author keywords

Adhesion molecule; Cytokine; E selectin; P selectin; P selectin glycoprotein ligand

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 6; LIGAND; PADGEM PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; INFLAMMATION; KIDNEY GRAFT; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; LEUKOCYTE ADHERENCE; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; T LYMPHOCYTE;

EID: 0030975020     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119457     Document Type: Article

References (59)

1. Carpenter, C.B. 1995. Long-term failure of renal transplants: adding insult to injury. Kidney Int. 48:s40-s44.
2. Naimark, D.M.J., and E. Cole. 1994. Determinants of long-term renal allograft survival. Transplant. Rev. 3:93-113.
3. Pirsch, J.D., R.J. Pleog, S. Grange, A.M. D'Alessandro, S.J. Knechtle, H.W. Sollinger, M. Kalayoglu, and F.O. Belzer. 1996. Determinants of graft survival after renal transplantation. Transplantation (Baltimore). 61:1581-1586.
4. Almond, P.S., A. Matas, K. Gillingham, D.L. Dunn, P.G. Payne, R. Gruessner, and J.S. Najarian. 1993. Risk factors for chronic rejection in renal allograft recipients. Transplantation (Baltimore). 55:752-757.
5. Goes, N., J. Urmson, V. Ramassar, and P.F. Halloran. 1995. Ischemic acute tubular necrosis induces an extensive local cytokine response. Transplantation (Baltimore). 59:565-572.
6. Weyrich, A.S., X.-L. Ma, D.J. Lefer, K.H. Albertine, and A.M. Lefer. 1993. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J. Clin. Invest. 91:2620-2629.
7. Rice, G.E., and M.P. Bevilacqua. 1989. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science (Wash. DC). 246:1303-1306.
8. Weller, A., S. Isenmann, and D. Vestweber. 1992. Cloning of the mouse endothelial selectins: expression of both E-and P-selectin is inducible by tumor necrosis factor alpha. J. Biol. Chem. 267:15176-15183.
9. Sako, D., X.-J. Chang, K.M. Barone, G. Vachino, H.M. White, G. Shaw, G.M. Veldman, K.M. Bean, T.J. Ahern, B. Furie, et al. 1993. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell. 75:1179-1186.
10. Kaufman, R.J., M.V. Davies, L.C. Wasley, and D. Michnick. 1991. Improved vectors for stable expression of foreign genes in mammalian cells by use of the untranslated leader sequence from EMC virus. Nucleic Acids Res. 19: 4485-4490.
11. Kukowska-Latallo, J.F., R.D. Larsen, R.P. Nair, and J.B. Lowe. 1990. A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group alpha (1,3/1,4) fucosyltransferase. Genes Dev. 4:1288-1303.
12. Bierhuizen, M.F.A., and M. Fukuda. 1993. Expression cloning of a cDNA encoding UDP-GlcNAc : Gal beta 1-3-GalNAc-R (GlcNAc to GalNAc) beta 1-6GlcNAc transferase by gene transfer into CHO cells expressing polyoma large tumor antigen. Proc. Natl. Acad. Sci. USA. 89:9326-9330.
13. Sako, D., K.M. Comess, K.M. Barone, R.T. Camphausen, D.A. Cumming, and G.D. Shaw. 1995. A sulfated peptide segment at the amino terminus of PSGL-1 is critical for P-selectin binding. Cell. 83:323-331.
14. De Luca, M., L.C. Dunlop, R.K. Andrews, J.V. Flannery, Jr., R. Ettling, D.A. Cumming, G.M. Veldman, and M.C. Berndt. 1995. A novel cobra venom metalloproteinase, mocarhagin, cleaves a 10-amino acid peptide from the mature N terminus of P-selectin glycoprotein ligand receptor, PSGL-1, and abolishes P-selectin binding. J. Biol. Chem. 270:26734-26737.
15. Vachino, G., X.-J. Chang, G.M. Veldman, R. Kumar, D. Sako, L.A. Fouser, M.C. Berndt, and D.A. Cumming. 1995. P-selectin glycoprotein ligand-1 is the major counter-receptor for P-selectin on stimulated T cells and is widely distributed in non-functional form on many lymphocytic cells. J. Biol. Chem. 270:21966-21974.
16. Hancock, W.W., R.H. Lord, A.J. Colby, T. Diamantstein, F.R. Rickles, C. Dijktra, N. Hogg, and N.L. Tilney. 1987. Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin. J. Immunol. 138:164-170.
17. Reinke, P., E. Fietze, W.D. Döcke, F. Kern, R. Ewert, and H.-D. Volk. 1994. Late acute rejection in long-term renal allograft recipients. Transplantation (Baltimore). 58:35-41.
18. Platzer, C., S. Ode-Hakim, P. Reike, W.-D. Döcke, R. Ewert, and H.-D. Volk. 1994. Quantitative PCR analysis of cytokine transcription patterns in peripheral mononuclear cells after anti-CD3 rejection therapy using two novel multispecific competitor fragments. Transplantation (Baltimore). 58:264-268.
19. Volk, H.-D., S. Müller, S. Yarkoni, T. Diamantstein, and H. Lorberboum-Galski. 1994. Mechanisms of dichotomous action of IL-2-pseudomonas exotoxin 40 (IL-2-PE40) on cell-mediated and humoral immune response. J. Immunol. 153:2497-2505.
20. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-161.
21. Nadeau, K.C., H. Azuma, and N.L. Tilney. 1995. Cytokine expression in chronic rejection: role for MCP-1 and RANTES. Proc. Natl. Acad. Sci. USA. 92:8729-8733.
22. Chehadeh, H.E., G. Zerlauth, and J.W. Mannhalter. 1995. Video image analysis of quantitative competitive PCR products: comparison of different evaluation methods. Biotechniques. 18:27-28.
23. Ley, K., and T.F. Tedder. 1995. Leukocyte interactions with vascular endothelium. J. Immunol. 155:525-528.
24. McEver, R.P., K.L. Moor, and R.D. Cummings. 1995. Leukocyte trafficking mediated by selectin carbohydrate interactions. J. Biol. Chem. 270: 11025-11028.
25. Berman, C.L., E.L. Yeo, J.D. Wencel-Drake, B.C. Furie, M.H. Ginsberg, and B. Furie. 1986. A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. J. Clin. Invest. 78:130-137.
26. McEver, R.P., J.H. Beckstead, K.L. Moore, L. Marshall-Carlson, and D.F. Bainton. 1989. GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J. Clin. Invest. 84:92-99.
27. Weller, A., S. Isenmann, and D. Vestweber. 1992. Cloning of the mouse endothelial selectins. Expression of both E-and P-selectin is inducible by tumor necrosis factor alpha. J. Biol. Chem. 267:15176-15183.
28. Gotsch, U., U. Jager, M. Dominis, and D. Vestweber. 1994. Expression of P-selectin on endothelial cells is upregulated by LPS and TNF-alpha in vivo. Cell Adhesion Commun. 2:7-14.
29. Larsen, E., A. Celi, G.E. Gilbert, B.C. Furie, J.K. Erban, R. Bonfanti, D.D. Wagner, and B. Furie. 1989. PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell. 59: 305-312.
30. Hamburger, S.A., and R.P. McEver. 1989. GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood. 75:550-554.
31. Lawrence, M.B., and T.A. Springer. 1990. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell. 65:859-873.
32. Weyrich, A.S., X.Y Ma, D.J. Lefer, K.H. Albertine, and A.M. Lefer. 1993. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion. J. Clin. Invest. 91:2620-2629.
33. Garcia-Criado, F.J., L.H. Toledo-Pereyra, F. Lopez-Neblina, M.L. Phillips, A. Paez-Rollys, and K. Misawa. 1995. Role of P-selectin in total hepatic ischemia and reperfusion. J. Am. Coll. Surg. 181:327-334.
34. Mulligan, M.S., M.J. Polley, R.J. Bayer, M.F. Nunn, J.C. Paulson, and P.A. Ward. 1992. Neutrophil-dependent acute lung injury. Requirement for P-selectin (GMP-140). J. Clin. Invest. 90:1600-1607.
35. Palabrica, T., R. Lobb, B.C. Furie, M. Aronovitz, C. Benjamin, Y.M. Hsu, S.A. Sajer, and B. Furie. 1992. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adhesion platelets. Nature (Lond.). 359:848-851.
36. Johnson, R.C., T.N. Mayadas, P.S. Frenette, R.E. Mebius, M. Subramaniam, A. Lacasce, R.O. Hynes, and D.D. Wagner. 1995. Blood cell dynamics in P-selectin-deficient mice. Blood. 86:1106-1114.
37. Subramaniam, M., S. Saffaropour, S.R. Watson, T.N. Mayadas, and D.D. Wagner. 1995. Reduced recruitment of inflammatory cells in a contact hypersensitivity response in P-selectin-deficient mice. J. Exp. Med. 181:2277-2282.
38. Grober, J.S., B.L. Bowen, H. Ebling, B. Athey, C.B. Thompson, D.A. Fox, and L.M. Stoolman. 1993. Monocyte-endothelial adhesion in chronic rheumatoid arthritis. J. Clin. Invest. 91:2609-2619.
39. Kansas, G.S. 1996. Selectins and their ligands: current concepts and controversies. Blood. 88:3259-3287.
40. Moore, K.L., N.L. Stults, S. Diaz, D.F. Smith, R.D. Cummings, A. Varki, and P.R. McEver. 1992. Identification of a specific glycoprotein ligand for P-selectin (CD62) on myeloid cells. J. Cell Biol. 118:445-456.
41. Bevilacqua, M.P., S. Stengelin, M.A. Gimbrone, and B. Seed. 1989. Endothelial leukocyte adhesion 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science (Wash. DC). 243:1160-1165.
42. Morgan, J.D., A. Lycett, T. Horsburgh, M.L. Nicholson, P.S. Veitch, and P.R.F. Bell. 1994. The importance of E-selectin as a marker for renal transplant rejection. Transplant. Clin. Immunol. 2:326-330.
43. Moore, K.L., S.F. Eaton, D.E. Lyons, H.S. Lichenstein, R.D. Cummings, and R.P. McEver. 1994. The P-selectin glycoprotein ligand from human neutrophils displays sialylated, fucosylated, O-linked poly-N-acetyllactosamine. J. Biol. Chem. 269:23318-23327.
44. Asa, D., L. Raycroft, L. Ma, P.A. Aeed, P.S. Kaytes, Å.P. Elhammer, and J.-G. Geng. 1995. The P-selectin glycoprotein ligand functions as a common human leukocyte ligand for P-and E-selectins. J. Biol. Chem. 270:11662-11670.
45. + hematopoietic progenitor cells. J. Cell Biol. 135:523-531.
46. Guyer, D.A., K.L. Moore, E.B. Lynam, C.M.G. Schammel, S. Rogelj, R.P. McEver, and L.A. Sklar. 1996. P-selectin glycoprotein ligand-1 (PSGL-1) is a ligand for L-selectin in neutrophil aggregation. Blood. 88:2415-2421.
47. Bischoff, J., and C. Brasel. 1995. Regulation of P-selectin by tumor necrosis factor-alpha. Biochem. Biophys. Res. Commun. 210:174-180.
48. Khew-Goodall, Y., C.M. Butcher, M.S. Litwin, S. Newlands, E.I. Korpelainen,.L.M. Noack, M.C. Berndt, A.F. Lopez, J.R. Gamble, and M.A. Vadas. 1996. Chronic expression of P-selectin on endothelial cells stimulated by the T-cell cytokine, interleukin-3. Blood. 87:1432-1438.
49. Frenette, P.S., T.N. Mayads, H. Rayburn, R.O. Hynes, and D.D. Wagner. 1996. Susceptibility to infection and altered hematopoiesis in mice deficient in both P-and E-selectins. Cell. 84:563-574.
50. Pinsky, D.J., Y. Naka, H. Liao, M.C. Oz, D.D. Wagner, T.N. Mayadas, R.C. Johnson, R.O. Hynes, M. Heath, C.A. Lawson, and D.M. Stern. 1996. Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. J. Clin. Invest. 97:493-500.
51. Norman, K.E., K.L. Moore, R.P. McEver, and K. Ley. 1995. Leukocyte rolling in vivo is mediated by P-selectin glycoprotein ligand-1. Blood. 86:4417-4421.
52. Rabb, H., G. Ramirez, S.R. Saba, D. Reynolds, J. Xu, R. Flavell, and S. Antonia. 1996. Renal ischemic-reperfusion injury in L-selectin-deficient mice. Am. J. Physiol. 271:F408-F413.
53. Bulkley, G.B. 1994. Reactive oxygen metabolites and reperfusion injury: aberrant triggering of reticuloendothelial function. Lancet. 344:934-936.
54. Kelly, K.J., W.W. Williams, Jr., R.B. Colvin, and J.V. Bonventre. 1994. Antibody to intracellular adhesion molecule 1 protects the kidney against ischemic injury. Proc. Natl. Acad. Sci. USA. 91:812-816.
55. Weiser, M.R., J.P. Williams, F.D. Moore, Jr., L. Kobzik, M. Ma, H.B. Hechtman, and M.C. Carroll. 1996. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J. Exp. Med. 183: 2343-2348.
56. Baldwin, W.M., S.K. Pruitt, R.B. Brauer, M.R. Daha, and F. Sanfilippo. 1995. Complement in organ transplantation. Transplantation (Baltimore). 59: 797-808.
57. Andrews, P.A., J.E. Finn, C.M. Lloid, W. Zhou, P.W. Mathieson, and S.H. Sachs. 1995. Expression and tissue localization of donor-specific complement C3 synthesized in human renal allografts. Eur. J. Immunol. 25:1087-1093.
58. Böttger, E.C., M.A. Blanar, and R.A. Flavell. 1988. Cycloheximide, an inhibitor of protein synthesis, prevents γ-interferon-induced expression of class II mRNA in a macrophage cell line. Immunogenetics. 28:215-220.
59. Larrick, J.W., D. Graham, K. Toy, L.S. Lin, G. Senyk, and B.M. Fendly. 1987. Recombinant tumor necrosis factor causes activation of human granulocytes. Blood. 69:640-644.